The spread of white supremacist propaganda across the United States nearly doubled over the last year, according to a new report released Wednesday by the Anti-Defamation League’s Center on Extremism.
The spread of white supremacist propaganda across the United States nearly doubled over the last year, according to a new report released Wednesday by the Anti-Defamation League’s Center on Extremism.
Fast growing RegTech company, Napier, which provides next-generation anti-money laundering (AML) solutions, has bolstered its senior management team with the appointments of new Global Human Resources Director, Lila Boyce, and EMEA Head of Sales, Roy Williamson.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics" report has been added to ResearchAndMarkets.com's offering. This "Clinical Genomics Report: The Interplay Between Clinical Research and Clinic Diagnostics" provides an in-depth analysis of differences in product characteristics related to data processing, analysis, knowledge extraction and reporting of findings (including the type of content integrated for meaningful extraction), and compliance and security mechanisms. Both clinical end-users and commercial companies who require insight into this expanding industry and its providers and products will benefit from the critical, investigative, and qualitative report. This new, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process (which includes genomic data generation, data flow, and data warehousing), clinical genomics data solution providers, market trends, technologies impacting clinical genomics applications development, clinical genomics adoption challenges, and detailed challenges & needs analysis as identified in discussions with clinical end-users. The report is unique, in that it is not a predictive market research report, but rather builds on data gathered from many end-user interviews combined with an extensive analysis of the clinical genomics sector. Report Contents: Leading medical organizations have established precision medicine programs that support personalized patient treatment. Implementation of clinical genomics applications and enterprise-wide clinical data warehouses are considered the foundation for successful genomic medicine programs. Innovative technological advancements have allowed us to sequence and uncover mutational events at an unprecedented scale while facilitating linking genomic data to high-quality clinical data and diagnosis. Medical organizations understand the benefit of being empowered by data-driven approaches to reduce operational costs and time and to provide researchers and clinicians what is necessary to decipher critical research data and data for clinical decision making. However, technical and scientific limitations still need to be addressed for optimized and universal use of various data sources for both clinical and research purposes. While data production is no longer a challenge, and targeted panels - and to some extent, whole-exome sequencing - are well adopted, the expected dramatic rise in whole-genome sequencing will result in unforeseeable quantities of data at the clinical level that needs to be managed, understood, and communicated. Low-cost sequencing of whole genomes at population scale is already in existence, but not yet widespread in the clinic, as many observed changes at the genome level cannot yet be fully interpreted or explain an existing phenotype. Scalable, fully automated analysis and knowledge extraction solutions incorporating rich annotation information are necessary to overcome these challenges. With massive quantities of NGS data (linked to different clinical and other types of data), artificial intelligence and machine learning are hailed as pivotal solutions to address the data interpretation and knowledge extraction challenges and to advance the clinical application of genomics. Despite increasing efforts and investments in implementing clinical applications and building data solutions, many organizations are still challenged with the multi-faceted complexities in transforming to become data-driven. Implementations are challenged by ineffective data sharing, scalability and automation issues, non-optimized data generation and data flow approaches and non-standardized data from numerous sources. Implementing a complex clinical data warehouse presents many challenges starting with the various data sources it needs to support and the tools required to view the clinical information. Ingestion of data of different types and origins with relevant metadata; data transformation, standardization, and cleansing to support the needs of a diverse set of end-users in both the clinical and research settings; and varied end-users with individual needs and computation capabilities are all important considerations. Clinical interviews detailed challenges associated with creating a workflow that incorporates a clinical data warehouse connecting clinical research with clinical diagnostics and vice versa. This important workflow leads to efficient clinical decision-making and reporting findings between clinical research and the clinic, which can optimize clinical outcomes and patient treatment. Key Topics Covered: 1. THE CLINICAL DIAGNOSTICS & MOLECULAR PROFILING WORKFLOW Clinical Genomics Workflow End Users/PersonasMapping End Users to the Clinical Genomics WorkflowClinical Information Delivery 2. THE PRECISION MEDICINE VALUE CHAIN 3. LEADING MEDICAL ORGANIZATIONS PLATFORM AND INFRASTRUCTURE PREFERENCES IN SUPPORT OF THEIR CLINICAL GENOMICS WORKFLOWS Implementations and Choices of Molecular Profiling and Genetic Testing ProcessesMedical Organizations' Clinical Genetic Testing LabsTesting Lab Selection CriteriaPlatforms and Infrastructures Currently Implemented at Leading Medical OrganizationsAdoption of Commercial and Internally Developed Platforms, Tools, and ServicesMedical Organizations Platform and Infrastructure PreferencesProfiles of Leading Medical OrganizationsCedars-SinaiEmory HealthcareGeisinger Health SystemsIntermountain HealthcareKaiser PermanenteMayo ClinicMD Anderson Cancer CenterMoffitt Cancer CenterMount Sinai Health SystemNationwide Children's HospitalPartners HealthCareSanford HealthSt. Jude Children's HospitalVanderbilt University Medical Center 4. MEDICAL INDUSTRY CHALLENGES Clinical Genomics - Unmet Needs and ChallengesTechnical Challenges Associated with Scaling Clinical Genomics ApplicationsScientific Challenges Associated with the Implementation of Clinical GenomicsNon-Technical / Scientific Challenges Associated with the Implementation of Clinical Genomics Applications 5. GENOMIC DATA GENERATION, DATA FLOW, AND DATA WAREHOUSING Rethinking Optimized Genomic Data Generation and Data FlowStructures of Successful Big Data PlatformsScalable Data Generation and Data Flow Lacking Data StandardsSlow Integration of Clinical Genomics Data with Other Clinical/Patient DataCurrent EMR/EHR Systems Do Not Support Genomics DataVariant Data Warehousing for Data Analysis, Mining, and QueryingEnterprise Data Platform ArchitectureIntegration of Various Types of DataA Data Warehouse That Supports Clinical ResearchData Warehousing and Fast Data Processing Requires a Scalable InfrastructureThe Ideal Variant Data Analysis and Query PlatformData Warehouse versus a Data LakeCloud Is the Preferred Infrastructure 6. CLINICAL GENOMICS DATA SOLUTIONS Genomic Data Infrastructures/Platforms for Data Storage, Processing, and AnalysisScaled Data Storage and Computing SolutionsClinical Genomics Data PlatformsIntegrated Genomic WorkflowData Processing Speed, Scalability, and FlexibilityClinical Data Management & Knowledge ExtractionClinico-Genomic Data Management and IntegrationGenomic/Variant Data Querying and AnalysisVariant Data Interpretation/Decision Making/ReportingTertiary Analysis - Sequence Data Interpretation and Insight GenerationTertiary Analysis - Embedded Interpretation Content for Insight GenerationData Processing, Knowledge Extraction, and Reporting Companies Side-by-Side 7. CLINICAL GENOMICS MARKET TRENDS Factors Impacting Clinical Sequencing AdoptionGenetic Testing and Molecular Profiling TrendsThe Increasing Trend of Clinical Genetic TestingClinical Genomics Applications to Be Established in the Clinic as a RoutineRoutine Genomic Applications Established over the Next Three to Five YearsRequirements to Establish Genomic Applications as a RoutineMergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical GenomicsAgilent Is Building Integrated, Complete Clinical Workflow SolutionsIllumina's M&As Suggest the Goal of a Fully Integrated Sequencing SolutionRoche Is Expanding its Diagnostics BusinessThermo Fisher Scientific Is Strengthening Its Presence in the Clinical SectorQIAGEN Is Pushing the Molecular Diagnostics and Clinical Research MarketsOther Acquisitions and Partnerships 8. TECHNOLOGIES IMPACTING THE IMPLEMENTATION OF CLINICAL GENOMICS & MOLECULAR PROFILING APPLICATIONS 3rd and 4th Generation Sequencing TechnologyArtificial Intelligence/Machine Learning ApplicationsAI in Healthcare Adoption DriversLiquid Biopsy in Clinical DiagnosticsLiquid Biopsy Clinical ApplicationsLong-Read Sequencing TechnologyReal-World Data / Real-World EvidenceThe FDA Is Attempting to Define RWD and RWEAn Uptick of RWD and RWE PublicationsThe Benefits of Real-World EvidenceThe Challenges of Using RWD and RWEAn Active Playing Field of Commercial RWD PlayersClinical Genomics Adoption Challenges 9. COVID-19, THE HEALTHCARE DISRUPTER Diagnostics - Commercial Companies RevampingDiagnostics Companies Quickly PivotedCOVID-19, a Disrupter, but also an OpportunityViral Sequencing Reveals How SARSCo-V-2 Evolves and SpreadsCOVID-19 Resulted in Unprecedented Data SharingCOVID-19 and the Massive Disruptions to Clinical Trials Processes 10. COMMERCIAL CLINICAL SOLUTIONS / PRODUCT PROVIDERS Company ProfilesBC PlatformsBluebee (an Illumina company)ColorCongenicaDNAnexusFabric GenomicsFoundation MedicineFreenomeGenooxGenuity ScienceGoogle Life SciencesGRAILHelixIlluminaInvitaePierianDxQIAGENSeven BridgesSOPHiA GeneticsTempus 11. THE FUNDING SITUATION 12. APPENDIX Clinical Genomics End User TypesThe Computational Scientist/BioinformaticianThe Data ScientistThe Non-Computational CollaboratorThe Genetic CounselorThe Clinical GeneticistThe PhysicianThe Patient 13. ABBREVIATIONSFor more information about this report visit https://www.researchandmarkets.com/r/hfqr98 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
(Bloomberg) -- Credit Suisse Group AG unloaded about $2 billion of stocks tied to the Archegos Capital Management blowup in the second such block sale since the bank wrote down the bulk of its exposure in the first quarter.The stock offerings included Discovery Inc. and Iqiyi Inc., adding to some $2.3 billion worth of shares tied to the debacle that the bank sold last week, according to people familiar with the matter. The trades follow a torrent of similar transactions that had already erased about $194 billion in market value as banks from New York to Zurich and Tokyo unwound leveraged equity bets by Bill Hwang’s family office.Shares of Credit Suisse fell as the sale adds to evidence that the Archegos collapse could impact the bank beyond the first quarter, when it took a 4.4 billion franc ($4.8 billion) writedown, its worst trading hit in more than a decade. While the Swiss bank has substantially reduced its exposure, transactions since the end of March weren’t included in the first-quarter results, a person familiar with the matter has said.Credit Suisse fell as much as 2.2% in early Zurich trading and was 1.2% lower by 9:43 a.m. The stock has lost 15% this year, compared with double-digit gains for an index that includes its European peers.A spokesperson for Credit Suisse declined to comment on the sale and whether the bank plans more such transactions.Hwang’s private investment firm became the center of one of the biggest margin calls of all time late last month, and represented one of the most spectacular failures of risk-management and oversight in recent memory. The downfall of Archegos will result in $10 billion of losses to banks, according to analysts at JPMorgan Chase & Co. The debacle could attract regulatory scrutiny and potential fines for the banks involved, the analysts said this week.Read more: Archegos Ripples Through Banks’ Lucrative Hedge Fund BusinessTuesday’s block trades -- which sold at the lower end of ranges -- included 19 million Class A shares of Discovery sold at $38.40, said one of the people, asking not to be identified discussing a private matter. In addition, 22 million Class C shares of Discovery sold at $32.35 while a stake of 35 million Iqiyi shares went for $15.85.Credit Suisse’s latest sale comes weeks after several rivals dumped their shares to skirt losses. While the firm was one of several global investment banks to facilitate the leveraged bets of Archegos, it was slower than others to unwind the positions and had initially tried to reach some sort of standstill agreement, people familiar with the matter have said.The strategy failed as rivals rushed to cut their losses. Global banks including Goldman Sachs Group Inc. and Deutsche Bank AG have told investors that they shed their Archegos-linked positions with little financial impact.Credit Suisse is now planning a sweeping overhaul of its hedge fund business. It has already announced plans to cut its dividend, suspend share buybacks and scrap bonuses for top executives.(Updates with Credit Suisse shares from third paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Revenue Prospects by Type (Primary Packaging (Blisters, Bottles, Pouches, Tubes, Others), Secondary Packaging (Labelling for Parenteral and Injectable, Just in Time Labelling, Tyvek Blistering for Parenteral, Cartons, Others)), End Users (Drug Manufacturing Companies, Research Labs and CROs), Profiles of Leading Companies and Regional and Leading National Market Analysis.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Trial Packaging and Labelling Market Forecast 2020-2030" - https://www.reportlinker.com/p06058481/?utm_source=GNW Clinical Trial Packaging and Labelling- our new study reveals trends, R&D progress, and predicted revenues Where is the Clinical Trial Packaging and Labelling market heading? If you are involved in this sector you must read this newly updated report. This report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 171 pages report provides 96 tables, 50 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Clinical Trial Packaging and Labelling Market. See how to exploit the opportunities. Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments. Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level. Clinical Trial Packaging and Labelling Market by Type Primary Packaging • Blisters • Bottles • Pouches • Tubes • Others Secondary Packaging • Labelling for Parenteral and Injectable • Just in Time Labelling • Tyvek Blistering for Parenteral • Cartons • Others Clinical Trial Packaging and Labelling Market by End Users • CRO’s • Drug Manufacturing Companies • Research Labs In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets: North America • U.S. • Canada • Latin America: • Brazil • Mexico • Rest of Latin America Europe (EU) • Germany • France • UK • Italy • Spain • Rest of Europe Asia-Pacific (APAC) • Japan • China • India • Australia • ASEAN • Rest of Asia-Pacific Middle East and Africa (MEA) • GCC Countries • South Africa • Rest of MEA Leading companies and the potential for market growth Overall world revenue for Clinical Trial Packaging and Labelling Market will surpass $900 million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Clinical Trial Packaging and Labelling Market report helps you In summary, our 181 pages report provides you with the following knowledge: • Revenue forecasts to 2030 for 5 regional and 17 key national markets- See forecasts for the Clinical Trial Packaging and Labelling market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa. • Prospects for established firms and those seeking to enter the market- including company profiles for 13 of the major companies involved in the Clinical Trial Packaging and Labelling market Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence. Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Clinical Trial Packaging and Labelling market and leading companies. You will find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058481/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Asphalt Pavers Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Screed Type; By Operating Weight; By Paving Width; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global asphalt pavers market size is expected to reach USD 1,410.03 million by 2027China is focusing on the development of its western region. In line with this, it has announced various infrastructure projects for the Tibet region as well. India is mainly focusing on the development of its transport network by investing heavily in road and rail infrastructure. Furthermore, the country is focusing on improving power infrastructure by building thermal, nuclear, wind, and solar power stations.Traffic has grown by 150 times over the last 50 years, while roads have increased by 9 times during the same period. The quality of roads in India is quite poor, leading to annual economic losses of US$ 4 Bn to US$ 7 Bn. The Indian construction equipment market has the potential to grow up to significantly, owing to the government's focus on infrastructure developments.Intelligent pavement refers to the pavement of asphalt using asphalt pavers equipped with global positioning systems (GPS) based mapping sensors and optional feedback controls. It is one of the most important progress made in roadway construction and has been widely adopted by Europe and China's manufacturers.In order to meet the changing need of the European market coupled with increasing demand for higher levels of operator comfort and safety. Despite their smaller dimensions, manufacturers are continuing to improve the operator's working environment by adding more comfort and safety features to their machines. For instance, Hamm's newly launched Asphalt Pavers enhance maximum possible operators' comfort, exceptionally good visibility, and the highest possible operational safety.Market participants such as Caterpillar, Sunroc Corporation, Astec Industry, Gencor Industries, Inc., Wirtgen group, Volvo CE, Ammann, Sumitomo, Fayat Group, Sany, Zoomlion, VT Leeboy, Shantui, and XCMG are some of the key players operating in the global market. Market players are focusing on mergers, acquisitions, technological advancements to have a competitive edge in the market. For instance, in July 2020, Gencor Industries announced a definitive agreement to acquire paver business from Blaw Knox, the Pennsylvania, U.S. based paver equipment manufacturer. Key Topics Covered: 1. Introduction2. Executive Summary3. Research Methodology3.1. Overview3.2. Data Sources4. Asphalt Pavers Market Insights4.1. Asphalt Pavers - Industry snapshot4.2. Asphalt Pavers Market Dynamics4.2.1. Drivers and Opportunities220.127.116.11. Strong government funding18.104.22.168. Introduction of new technologies4.2.2. Restraints and Challenges22.214.171.124. Cost escalations4.3. Porter's Five Forces Analysis4.4. PESTLE Analysis4.4.1. Asphalt Pavers Market Industry trends5. Asphalt Pavers Market Assessment by Product Type5.1. Key Findings5.2. Introduction5.3. Tracked Pavers5.4. Wheeled Pavers6. Global Asphalt Pavers Market, by Screed Type6.1. Key Findings6.2. Introduction6.3. Hydrostatic6.4. Mechanical7. Global Asphalt Pavers Market, by Operating Weight7.1. Key Findings7.2. Introduction7.3. 5000-8000 Kgs7.4. 8000-12000 Kgs7.5. 12000-15000 Kgs7.6. Over 15000 Kgs8. Asphalt Pavers Market Assessment by Paving Width8.1. Key Findings8.2. Introduction8.3. Up to 1.5 m8.4. 1.5-2.5 m8.5. 2.5-5 m8.6. Over 5 m9. Asphalt Pavers Market Assessment by Geography9.1. Key findings9.2. Introduction9.2.1. Asphalt Pavers Market Assessment, By Geography, 2016-2027 (USD Million)10. Competitive Landscape10.1. Expansion and Acquisition Analysis10.1.1. Expansion10.1.2. Acquisitions10.2. Partnerships/Collaborations/Agreements/Exhibitions11. Company Profiles11.1. Company Overview11.2. Financial Performance11.3. Product Benchmarking11.4. Recent Developments CaterpillarAstec IndustryWirtgen groupVolvo CEAmmannSumitomoFayat GroupSanyZoomlionVT LeeboyShantuiXCMG For more information about this report visit https://www.researchandmarkets.com/r/nmqivk CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Three prominent members of the global Scrabble players’ organisation quit in response to the changes
Senior MEP says ‘cool heads must prevail’ in holding UK to commitments
Amnesty International, Privacy International and 28 other civil and human rights groups on Wednesday urged EU lawmakers to take a strong stand on privacy rights in proposed rules governing Facebook's WhatsApp and Microsoft's Skype. The call by the group in a letter to the European Parliament, whose members are spread out across Europe, is in response to what they said are attempts by EU countries to weaken privacy rights. EU countries in February agreed to a joint position in forthcoming negotiations with EU lawmakers and the European Commission on an ePrivacy Regulation that would subject WhatsApp and Skype to the same rules as telecoms providers and restrict the tracking of users in order to provide personalised ads.
China Southern Airlines is reviewing the future of the five Airbus A380 superjumbos in its fleet, an executive said on Wednesday, at a time when many carriers are retiring the jets early because of the COVID-19 pandemic. "Not only for China Southern but also for many airlines we must be thinking about the A380," China Southern Senior Vice President International and Corporate Relations Wu Guoxiang said at a CAPA Centre for Aviation event. China Southern is the only Chinese A380 operator and is running only 10% of its overall pre-pandemic international capacity because of border restrictions, Wu said.
Forecasts by Type (Clinical Trial Manufacturing (Clinical Trial Packaging, Others), Clinical Trial Logistics and Distribution (Clinical Trial Cold Chain Logistics, Others), Clinical Trial Supply Chain Management), by End Users (CRO’s, Pharma & Biotech, Others (Academics, Research Institutes etc.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Trial Supply and Logistics Market for Pharma 2020-2030" - https://www.reportlinker.com/p06058482/?utm_source=GNW )) PLUS COVID-19 Impact AnalysisThe global clinical trials supply and logistics market for pharma is estimated to have reach $10.3bn in 2019, dominated by the clinical trial manufacturing segment. The global clinical trial supply and logistics market for pharma is expected to grow at a CAGR of 6.6 % in the first half of the forecast period. This new report also covers the economic impact of COVID-19 as well as how the pandemic will affect your industry sector. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 178-page report you will receive 81 charts– all unavailable elsewhere. The 178-page report provides clear detailed insight into the global clinical trial supply and logistics market for pharma. Discover the key drivers and challenges affecting the market. The report also includes insight on how COVID-19 will affect your industry. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope • Revenue and growth forecasts from 2020 to 2030 for the global clinical trial supply and logistics market. This report also discusses the Drivers and Restraints of the global clinical trial supply and logistics market. • Revenue and growth forecasts from 2020 to 2030 for the leading submarkets of the global clinical trial supply and logistics market: • Manufacturing – also with sub forecasting for packaging and for other production • Logistics and distribution – also with sub forecasts for cold chain logistics and for other services • Supply chain management This report discusses the Drivers and Restraints of each submarket. • Revenue and growth forecasts from 2019 to 2029 for the leading national markets: • United States • Japan • EU5: Germany, France, United Kingdom, Italy, Spain • Brazil • Mexico • China • India • GCC • South Africa • Rest of the World Revenues forecast for the US, Japan, EU5, Brazil, Mexico, China, India, GCC, South Africa are further broken down by submarket. • This report profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry: • ADAllen Pharma • Almac Group • Amatsigroup • Catalent • DHL • FedEx • Fisher Clinical Services • Marken • Parexel International • Sharp Packaging Services, LLC • Many others • This report provides qualitative analysis of the clinical trial supply and logistics market. This report discusses the Strengths, Weaknesses, Opportunities and Threats of the clinical trial supply and logistics market. Social, Technological, Economic and Political factors that influence this market are also discussed. • This report discusses trends in the clinical trial supply and logistics market, clinical trial manufacturing market, comparator sourcing, clinical trial packaging, clinical trial supply chain management. • This report discusses the regulatory outlook of the clinical trial supply and logistics industry, outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials • Key Questions Answered by this Report: • How is the clinical trial supply and logistics market for pharma evolving? • What are the drivers and restraints for the growth of the clinical trial supply and logistics market for pharma? • How will each clinical trial supply and logistics submarket for pharma grow over the forecast period and how much revenue will these submarkets account for in 2030? • How will the market shares for each clinical trial supply and logistics submarket for pharma develop to 2030? • What is the value of the leading clinical trial supply and logistics submarket for pharma s in important regions of the world? • What will be the main driver for the overall market to 2030? • How will the market shares of the national markets change by 2030 and which geographical region will lead the market by 2030? • Who are the leading players and what are their prospects over the forecast period? This study is intended for anyone requiring commercial analyses for the global clinical trial supply and logistics market for pharma. You find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058482/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The time has come, self-contained staycations are officially allowed again. Abha Shah picks the hottest listings to book now
Broncos coach Kevin Walters has hit out at critics after a poor start to the season.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Industrial Heating Equipment Market Analysis By Product, By Application And Segment Forecasts, 2017-2026" report has been added to ResearchAndMarkets.com's offering. The growing construction industry and an increase in demand for energy-efficient solutions are likely to stimulate demand for industrial heating equipment.The Global Industrial Heating Equipment Market size is expected to reach USD 33.88 billion by 2027 After a disappointing trade flow in 2016-2017, global trade in the first half of 2018 has shown significant improvement owing to low global manufacturing output along with unstable crude oil prices. Moving forward, the vulnerability in raw material prices remains a concern, along with unpredictable trade policies adopted by major consumers and manufacturers. The chemical and mining sectors accounted for the largest share in the industrial heating equipment market. This has been calculated on the basis of chemical industries outlook for the future by precedence to a capacity addition of the chemical and the mineral, material, and mining industries. An increase in demand for residential buildings in developed economies, driven by low-interest rates, a decrease in unemployment rates, and low debt service ratios, will positively contribute to the construction activities, which will aid in the growth of the industrial heating equipment market.Further key findings from the report suggest The heat pump segment was valued at USD 2.53 billion in 2019 and is estimated to reach USD 3.46 billion by the end of the forecast period. The segment is anticipated to grow at a CAGR of 4% due to an exponential increase in the capacity of SMEs under the specialty chemical industry in Asia. This segment registered a decline in production by 11% during 2014-2016; however, it is expected to pick up the pace by the end of 2019.The U.S. region is expected to grow significantly during the forecast period at a CAGR of 4.6%. The industrial sector in the U.S. contributed to over 30% of the thermal demand in the region. In 2010, the petroleum refining and chemicals industries accounted for 31% and 20% of the total process heating energy use, respectively. The petroleum refining and chemical industries use more than 1 quad of energy each for process heating.The demand for thermal energy varies from 900 GJ to 3.6 TJ depending on the size of a refinery plant. The industrial manufacturing sector of Canada accounts for nearly 65% of the thermal energy demand. The paper & pulp and petroleum refining industries are the largest consumers of industrial heating equipment.Key participants in the industry include Danfoss, Ingersoll-Rand Plc, Lennox International, Inc., Daikin Industries Ltd., Robert Bosch GmbH, Johnson Controls, Uponor Corporation, United Technologies Corporation, Emerson Electric Co. and Honeywell International Inc.In 2018, Danfoss acquired shares in Finland-based developer and provider of turnkey IoT solutions, Leanheat. Danfoss plans to strengthen its global position in building energy optimization and management. Key Topics Covered: Chapter 1. Market SynopsisChapter 2. Executive SummaryChapter 3. Indicative MetricsChapter 4. Industrial Heating Equipment Market Segmentation & Impact Analysis4.1. Industrial Heating Equipment Segmentation Analysis4.2. Industrial Outlook4.3. Regulatory Framework4.4. Industrial Heating Equipment Market Impact Analysis4.4.1. Market driver analysis126.96.36.199. Growing Construction Industries188.8.131.52. Demand for energy efficient solutions4.4.2. Market restraint analysis184.108.40.206. High Costs4.5. Key opportunities prioritized4.6. ETOP Analysis4.7. Porter's Five Forces Analysis4.8. Competitive Metric Space Analysis4.9. Price trend AnalysisChapter 5. Industrial Heating Equipment Market By Product Insights & Trends5.1. Product Dynamics & Market Share, 2018 & 20265.2. Heat Pumps5.3. Furnaces5.4. Unitary Heaters5.5. Boilers5.6. Radiant HeatersChapter 6. Industrial Heating Equipment Market By Application Insights & Trends6.1. Application Dynamics & Market Share, 2018 & 20266.2. Oil & Gas6.3. Mining Materials & Metals6.4. Machinery Manufacturing Industry6.5. Automotive6.6. ChemicalChapter 7. Industrial Heating Equipment Market Regional Outlook7.1. Industrial Heating Equipment Market share by region, 2018 & 2026Chapter 8. Competitive Landscape8.1. Market Revenue Share by Manufacturers8.2. Manufacturing Cost Breakdown Analysis8.3. Mergers & Acquisitions8.4. Market positioning8.5. Strategy Benchmarking8.6. Vendor LandscapeChapter 9. Company Profiles DanfossUnited Technologies CorporationIngersoll-Rand PlcLennox International Inc.Daikin Industries Ltd.Johnson ControlsRobert Bosch GmbHUponor CorporationEmerson Electric Co.Honeywell International Inc. For more information about this report visit https://www.researchandmarkets.com/r/8qgmjc CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Thailand reported on Wednesday 1,335 new COVID-19 cases, the biggest daily rise since the start of the pandemic and the third record rise this week, as the Southeast Asian country struggles with a new wave of infections. The spike in cases comes as Thais celebrate the Songkran new year holidays and authorities have urged people to avoid unnecessary travel and reduce gatherings to help limit the outbreak, which includes the highly transmissible B.1.1.7 variant first identified in Britain. "The period after Songkran is a critical time to control the outbreak, if not we could see 10,000 to 20,000 cases per day," senior health official, Opas Karnkawinpong, said, urging people to work from home for two weeks after the holidays.
Check delivery details carefully with each restaurant, as many don’t deliver throughout the week. For a taste of that Mykonos minibreak you had to cancel, call in some DIY souvlaki (grilled meat wrapped in Greek flatbread and layered with sauces, if you’re not familiar with the glorious Greek comfort food).
Russia's rouble extended strong gains on Wednesday on hopes of improving ties between Moscow and the West, while other emerging market currencies rose as U.S. inflation data failed to stoke fears of imminent policy tightening. The rouble led gains across currencies in Europe, the Middle East and Africa, having surged 1.8% on Tuesday after a phone call between U.S. President Joe Biden and Russian President Vladimir Putin, which the Kremlin said was a proposal to normalise ties.
Lawrenceville, GA, April 14, 2021 (GLOBE NEWSWIRE) -- RealManage is pleased to announce Jan Vasser's promotion, a Georgia team member, to Director of Community Association Management. Jan joined our RealManage team in 2018 and received the promotion to the director of association management for the Georgia branch. She has an extensive background in community management spanning over 20 years and began her management experience managing market, LIHTC, and over 55 communities for one of the largest management companies in the State of Georgia. “It’s exciting to be on board with one of the top HOA management companies in the nation,” states Jan. “I’m proud to be part of the RealManage team and an integral part of the Georgia branch/division. GO DAWGS!” She holds her degree in Business Administration, her CMCA® designation from the Community Association Institute, and a CPM issued by the State of Georgia Department of Community Development. “Jan has been a fantastic leader, and it’s an honor to have her accept the position of director of community association management with our organization,” states Georgia Division President Gary Griffin. “I know she will be tremendously successful in her new role.” About RealManageRealManage is a community management company managing close to two thousand community associations across the nation. Areas of operation include California, Colorado, Florida, Illinois, North Carolina, South Carolina, Georgia, Nevada, Texas, and Washington. The company provides services to homeowner associations (HOAs), condominium associations, cooperatives, municipal utility districts, luxury high-rises, and large master-planned communities. Learn more about RealManage at www.realmanage.com. Connect with Us: FacebookTwitterLinkedInInsights Blog CONTACT: Amanda Causey RealManage email@example.com
Press Release Public tender offer on Natixis’ shares, followed by a potential mandatory squeeze-out Paris, April 14th 2021 Having noted that the opening of the simplified tender offer for Natixis’ shares will most likely occur after the detachment of the 2020 dividend proposed to the vote of Natixis’ shareholders at the next General Meeting scheduled for May 28, 2021, the Supervisory Board of Group BPCE has decided to amend the terms of the offer to provide that the price of 4.00 euros per Natixis share is "ex-dividend". About Groupe BPCE Groupe BPCE, with its business model as a universal cooperative bank represented by 9 million cooperative shareholders, is currently the 2nd-largest banking group in France. With its 105,000 employees, it serves a total of 36 million customers – individuals, professionals, corporates, investors, and local government bodies – around the world. It operates in the retail banking and insurance sectors in France via its two major Banque Populaire and Caisse d’Epargne banking networks, along with Banque Palatine. With Natixis, it also runs global business lines specializing in Asset & Wealth management, Corporate & Investment Banking, Insurance and Payments. Through this structure, it is able to offer its customers a comprehensive, diversified range of products and services: solutions in savings, investment, cash management, financing, and insurance. The Group's financial strength is recognized by four financial rating agencies: Moody's (A1, stable outlook), Standard & Poor's (A+, negative outlook), Fitch (A+, negative outlook) and R&I (A+, stable outlook). About Natixis Natixis is a French multinational financial services firm specialized in asset & wealth management, corporate & investment banking, insurance and payments. A subsidiary of Groupe BPCE, the second-largest banking group in France through its two retail banking networks, Banque Populaire and Caisse d’Epargne, Natixis counts nearly 16,000 employees across 38 countries. Its clients include corporations, financial institutions, sovereign and supranational organizations, as well as the customers of Groupe BPCE’s networks. Listed on the Paris stock exchange, Natixis has a solid financial base with a CET1 capital under Basel 3(1) of €12.1 billion, a Basel 3 CET1 Ratio(1) of 11.6% and quality long-term ratings (Standard & Poor’s: A+ / Moody’s: A1 / Fitch Ratings: A+). Groupe BPCE Press Contact Christophe Gilbert: +33 1 40 39 66 00 firstname.lastname@example.org Groupe BPCE Investor Relations Roland Charbonnel: +33 1 58 40 69 30 François Courtois: +33 1 58 40 46 69 email@example.com Attachment PR_Groupe_BPCE_Offre_publique_achat_action_natixis_14042021_GB
The rising humic acid demand from the agriculture industry to increase yield is expected to drive the product demand over the forecast period.Selbyville, Delaware, April 14, 2021 (GLOBE NEWSWIRE) -- Based on Global Market Insights Inc., report, the global Humic Acid Market was estimated at $494.9 million in 2020 and is slated to exceed $1 billion by 2027, registering a CAGR of 11.9% from 2021 to 2027. The report provides a thorough analysis of the main investment avenues, major winning strategies, drivers and opportunities, wavering industry trends, market estimations as well as size, competitive scenarios. Major growth indicators in agriculture, ecological bioremediations, horticulture, and dietary supplement industries are analyzed to be the major factors propelling the overall humic acid demand over the estimated timespan. Humic acid is used to provide root system nourishment, prevent soil erosion and nitrogen leaching, and increase the immune system in plants and human beings. The eco-friendly nature of the product coupled with favorable government policies is anticipated to boost the humic acid market share. Covid-19 Synopsis: COVID-19 pandemic has affected various participants in the industry value chain. The value chain of the global humic acid market is complex and has multiple participants involved such as raw material suppliers, product manufacturers, channel partners (distributors/marketers), and end-consumers. There is an indirect presence of regulators and policymakers in the value chain. The value chain also has a strong influence on investment firms and financial bodies. The shortage of funds and limited availability of labor further affected capacity utilization during the first half of 2020. Product manufacturers faced a severe impact during the first few months of the pandemic. The demand drops from end-consumers along with the disruption of the supply chain created challenges for industry participants. Request for Sample Report: https://www.gminsights.com/request-sample/detail/1517 Growing public concerns over the potential health hazards of synthetic fertilizers coupled with a steep increase in the cost of cultivation result in low profits among farmers. It has led to the need to minimize the use of synthetic materials in the farming sector. Increasing regulations on synthetic fertilizers, especially in the European Union will drive the humic acid demand in the coming years. Moreover, the EU passed new legislation for an effective legal framework for the organic farming industry that came into force on 1 January 2021. This legislation coupled with increased consumer interest in organic products shall drive the humic acid market growth during the forecast period. The dietary supplements to lead the trail by 2027: The dietary supplement application segment accounted for an 11.6% share of market volume in 2020 and has a huge growth potential during the forecast period. Rising awareness pertaining to the health benefits of the product will influence the dietary supplements application segment in the coming years. It is gaining traction for stimulating the human immune system and for detoxification of the human body. Further, the mineral-rich content of the product helps in tackling diseases such as influenza and the common cold. MEA, followed by North America, to maintain its lead position by 2027: The Middle East & Africa is slowly gaining momentum in recent years and shall exceed revenue over USD 40 million by 2027. The growing changes in farming techniques in the region coupled with the increasing adoption of humic acid products are projected to be the major factors attributing to the humic acid market revenue in this region. The producers in this region are moving toward specialty products to increase yields and lower water consumption, which are prime concerns in this region. North America captured a major chunk of the total industry and shall exceed revenue over USD 390 million by 2027, owing to the decreasing trend observed in the agricultural land, primarily in the U.S., which has raised concerns for fulfilling increasing food demand owing to increasing population. Increasing food demand has propelled product usage to enhance production yield in limited agricultural land. Humic acid is an excellent substitute for chemical-based fertilizers as it is formed from organic content, which helps in improving soil fertility & nutrition value and in reducing harmful human health & environmental implications, thereby encouraging sustainable agricultural practices across the globe. Request for customization of this report: https://www.gminsights.com/roc/1517 Humic acid holds a huge scope for Rhodes grass, watermelon, cucumber, alfalfa, orange groves, grapes, onion, date trees, etc. The combined annual production of fresh dates in the Middle East countries has been over four million tons. A wide range of vegetables including tomato, eggplant, cucumber, and pumpkin are grown in the region, representing higher growth potential for the product primarily in the horticulture segment. However, the lack of awareness toward organic fertilizers has resulted in capturing a limited market share in the region. Leading market players: The Humic Acid industry share is competitive and includes manufacturers such as The Anderson, Inc., Daymsa, Faust Bio-Agricultural Services, Black Earth Humic LP, Biolchim S.p.A., Changsha Xian Shan Yuan, Humintech GmbH, and Agbest Technology Co., Limited. The companies are increasing their production capacities to suffice the growing product demand from the past few years. About Global Market Insights Inc. Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider. Offering syndicated and custom research reports, growth consulting and business intelligence services, Global Market Insights, Inc. aims to help clients with penetrative insights and actionable market data that aid in strategic decision making. GMIPulse, our business analytics platform offers an online, interactive option of exploring our proprietary industry research data in an easy-to-use and dynamic manner. Clients get to explore market intelligence across 11 top-level categories and hundreds of industry segments within them, covering regional, company level and cross-sectional statistics that make our offering a stand-out for decision-makers. CONTACT: Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: firstname.lastname@example.org Web: https://www.gminsights.com
Lawrenceville, GA, April 14, 2021 (GLOBE NEWSWIRE) -- RealManage is pleased to announce the promotion of Sheri Black, a member of the Georgia team, to Director of Community Association Management.Sheri joined the RealManage team in 2019 through the RealManage/GW & Associates merger. She brought ten years of experience in the industry from the ground floor to where she is today. Sheri shares, “I feel there are new things to learn daily and welcomes the knowledge and challenges that are to come with being a Director of Community Association Management.” One of Sheri’s favorite quotes that she applies in her professional and personal life is, “yesterday is a memory, and tomorrow is a dream." “Sheri has been a fantastic leader, and it’s an honor to have her accept the position of director of community association management with our organization, states Division President Gary Griffin. “I know she will be very successful in her new role.”About RealManageRealManage is a community management company managing close to two thousand community associations across the nation. Areas of operation include California, Colorado, Florida, Illinois, North Carolina, South Carolina, Georgia, Nevada, Texas, and Washington. The company provides services to homeowner associations (HOAs), condominium associations, cooperatives, municipal utility districts, luxury high-rises, and large master-planned communities. Learn more about RealManage at www.realmanage.com. Connect with Us:Facebook Twitter LinkedIn Insights Blog CONTACT: Amanda Causey RealManage email@example.com